Actively Recruiting
D20054;LITT for Spine Tumors
Led by Dartmouth-Hitchcock Medical Center · Updated on 2026-02-06
25
Participants Needed
1
Research Sites
263 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
CONDITIONS
Official Title
D20054;LITT for Spine Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed spinal tumor involving the T2-T12 spine segments
- Indication for spine stereotactic radiosurgery or palliative intervention
- Normal neurologic exam at the time of presentation (Frankel grade E)
You will not qualify if you...
- Contraindication to MRI
- Any neurologic deficit
- Tumor spanning more than 3 consecutive vertebral segments
- Contraindication to general anesthesia
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dartmouth Health
Lebanon, New Hampshire, United States, 03766
Actively Recruiting
Research Team
L
Lauren Sinks, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here